Bioengineers will explore the adaption of groundbreaking research into practical and commercial applications for healthcare at the 2nd Bioengineering and Translation Medicine Conference, October 28–29, 2017, in Minneapolis, MN. The conference is organized by the Society for Biological Engineering (SBE) of the American Institute of Chemical Engineers (AIChE), with support from the U.S. National Science Foundation.
The Bioengineering and Translation Medicine Conference (http://bio.aiche.org) runs in conjunction with the 2017 AIChE Annual Meeting (October 29–November 3) at the Minneapolis Convention Center and the Hilton Minneapolis.
Translational medicine embodies an interdisciplinary approach to driving chemical and biological engineering innovations into clinical practice and commercial healthcare products. The conference will feature sessions devoted to topics including biopharmaceuticals, genetic and stem cell engineering, patient-targeted therapies, immunoengineering, regenerative medicine, and biomanufacturing. The conference is chaired by Ali Khademhosseini, director of the Biomaterials Innovation Research Center and professor at Harvard Medical School; and Efie Kokkoli, professor of chemical engineering at the University of Minnesota.
The programming of the Bioengineering and Translational Medicine Conference complements the subject matter presenting in SBE’s and AIChE’s journal, Bioengineering & Translational Medicine (BioTM), published by John Wiley and Sons. Launched in 2015, BioTM is an open access journal that provides global and free access to innovative research on the clinical translation of biological engineering principles. Visit the BioTM website (http://www.bioengtransmed.com) for more information.
Established in 2004, the Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE’s mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. http://bio.aiche.org.
AIChE is a professional society of more than 53,000 chemical engineers in 110 countries. Its members work in corporations, universities and government using their knowledge of chemical processes to develop safe and useful products for the benefit of society. Through its varied programs, AIChE continues to be a focal point for information exchange on the frontiers of chemical engineering research in such areas as energy, sustainability, biological and environmental engineering, nanotechnology and chemical plant safety and security. More information about AIChE is available at http://www.aiche.org.